Posted by
Flashing Lights and Odd-Ball Beeps: The Tools that Help PASWFL Map and Treat Depression

Flashing Lights and Odd-Ball Beeps: The Tools that Help PASWFL Map and Treat Depression

Quantitative Electroencephalograms (QEEG’s) Help us ‘See’ Depression QEEGs have allowed us to repurpose existing neurological tests to help us better diagnose and treat major depressive, and related, disorders. Until now, we have bolstered a solid history and mental status examination with direct patient queries, objective written tests and scales. Technology and neurochemistry have given us […]

Posted by
AMA: Do Not Use Electronic Cigarettes

AMA: Do Not Use Electronic Cigarettes

HealthDay News – Americans should not use electronic cigarettes while health officials investigate cases of severe lung illness that may be linked to the devices, according to a statement issued by Patrice A. Harris, MD, president of the American Medical Association. “In light of increasing reports of e-cigarette-associated lung illnesses across the country, the AMA […]

Posted by
Unlocking the Mysteries of the Glutamate System

Unlocking the Mysteries of the Glutamate System

Ketamine, Similar Compounds Emerging as Mood Disorder Treatments Sanjay J. Mathew, MD, vice chair for research at Baylor College of Medicine and staff physician at the Michael E. Debakey VA Medical Center in Houston, Texas, has long been interested in the brain’s glutamate system and how it could be manipulated with substances such as ketamine to […]

Posted by
US health officials report new vaping deaths, repeat warning

US health officials report new vaping deaths, repeat warning

NEW YORK (AP) — U.S. health officials on Friday again urged people to stop vaping until they figure out why some are coming down with serious breathing illnesses. Officials have identified about 450 possible cases, including as many as five deaths, in 33 states. The count includes newly reported deaths in California, Indiana and Minnesota. […]

Posted by
Trial of SAGE-217 in Patients with Major Depressive Disorder

Trial of SAGE-217 in Patients with Major Depressive Disorder

Handan Gunduz-Bruce, M.D.,  Christopher Silber, M.D.,  Inder Kaul, M.D.,  Anthony J. Rothschild, M.D.,  Robert Riesenberg, M.D.,  Abdul J. Sankoh, Ph.D.,  Haihong Li, Ph.D.,  Robert Lasser, M.D.,  Charles F. Zorumski, M.D.,  David R. Rubinow, M.D.,  Steven M. Paul, M.D.,  Jeffrey Jonas, M.D.,  et al. Abstract BACKGROUND Altered neurotransmission of γ-aminobutyric acid (GABA) has been implicated in […]

Posted by
Adjunctive Riluzole Shows Promise in Treatment-Resistant Depression

Adjunctive Riluzole Shows Promise in Treatment-Resistant Depression

The glutamate blocker riluzole may have longer-term beneficial effects as adjunctive treatment for some patients with treatment-resistant depression, according to results of a trial published in the Journal of Affective Disorders. The US Food and Drug Administration approved riluzole for the treatment of amyotrophic lateral sclerosis in 1994. It inhibits presynaptic release of glutamate and acts directly […]

Posted by
Frequent Use of Medications for Sleep May Increase Dementia Risk, Especially Among Older White Adults

Frequent Use of Medications for Sleep May Increase Dementia Risk, Especially Among Older White Adults

Frequent use of sleep medications appears to be associated with increased long-term risk of dementia, particularly among older white adults, according to research presented at the Alzheimer’s Association International Conference in Los Angeles this week. “Based on our findings, we recommend that clinicians make more effort to be aware of their patients’ sleep problems including […]